(NYSEMKT: MYO) Myomo's forecast annual revenue growth rate of 6.1% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.47%.
Myomo's revenue in 2026 is $43,261,848.On average, 6 Wall Street analysts forecast MYO's revenue for 2026 to be $1,777,521,272, with the lowest MYO revenue forecast at $1,657,430,258, and the highest MYO revenue forecast at $1,898,364,834. On average, 6 Wall Street analysts forecast MYO's revenue for 2027 to be $2,008,910,355, with the lowest MYO revenue forecast at $1,754,469,501, and the highest MYO revenue forecast at $2,349,102,213.
In 2027, MYO is forecast to generate $2,007,642,904 in revenue, with the lowest revenue forecast at $1,754,469,501 and the highest revenue forecast at $2,280,580,625.